Global Pregnancy Testing Market
Pregnancy testing kits are used for early detection of pregnancy. Home pregnancy tests are simple and easy to use, inexpensive and provide accurate results within minutes. Most of the pregnancy tests are being taken in the home provides. The resulting accuracy is up to 97% to 99% when they are used as per the instructions. Urine pregnancy kit will be used for the detection of HCG hormone, a hormone which is only produced in the body of the pregnant woman. HCG production will be increased in initial days of the pregnancy which will be getting doubled for every 2-3 days in blood. Presence of HCG above a specific range will confirm pregnancy.
Pregnancy Testing Market Growth Analysis
Growing awareness regarding the availability of pregnancy test kits and utilization of the self-detection pregnancy kits and benefits has expected to create demand for pregnancy test kits. Moreover, a rise in disposable income, increased healthcare expenditure, adoption of technological advancements to detect pregnancy are few factors enables stimulate the market. However, price sensitivity of pregnancy detection kits is making unaffordable for the women in underdeveloped and developing regions. Lack of technical expertise in a woman is major restraints of the market.
A surge in the number of unintended pregnancies increased awareness among women is expected to offer enormous growth opportunities for the market players. According to World Health Organization statistics, in 2015 over 40% of the pregnancy cases which are reporting every year are unintended & about 10% of the pregnancy cases were of teenage. A rise in the number of unintended pregnancies is expected to create demand for pregnancy test kits. Moreover, increasing promotional campaigns undertaken by the manufacturers like celebrity endorsing in order to influence the rural people about utilization of the pregnancy detection devices is expected to bolster pregnancy testing market growth. The market is growing due to reasons like 99% accuracy rate in identifying HCG levels from the day of an expected period of the women. Manufacturers are focussing on the new product launches, market expansions, mergers, acquisitions and collaborations which are also showing positive influence on the growth of the market.
The Global pregnancy testing market segmentation by product, test type, distribution channel, and geography.
Based on product, the market is segmented as
- Pregnancy rapid test kits
- Line indicator devices
- Digital devices
- Fertility rapid test
Based on test type, the global market is segmented as
- Follicle stimulating hormone (FSH) test
- Human chorionic gonadotropin hormone blood test
- Urine test
- Luteinizing hormone (LH) test
Based on distribution channel, market is segmented as
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Gynaecology clinics
- Hypermarkets or supermarkets
Global Pregnancy Testing Market regional segmentation by Europe, Asia- Pacific, North America, Europe, Middle East & Africa and Latin America. North America is expected to dominate the pregnancy testing market owing to high healthcare expenditure and awareness programmes by companies for effective usage of pregnancy test kits. Europe is expected to expand at robust growth rate owing to the high adaptation of the digital pregnancy detecting kits along with the increasing disposable incomes. Asia Pacific is anticipated to show a significant growth owing to the increasing adaptation of pregnancy testing kits in the rural areas. Latin America is also emerging as a significant market owing to the growing awareness regarding the benefits of the early pregnancy detection and affordability of pregnancy detection kits.
Pregnancy testing market key players are Procter & Gamble Co (U.S.)., Alere Inc. (U.S.), Church & Dwight (U.S.), Germaine Laboratories (U.S.), SPD Swiss Precision Diagnostics (Switzerland), Piramal Enterprises (India), Abbott Laboratories (U.S.), DCC plc (Ireland), Cardinal Health (U.S.), Prestige Brands Holdings (U.S.), Kent Pharmaceuticals (UK), and Quidel Corporation (U.S.).
- In 2015 April, Abbott Laboratories received U.S. FDA approval for its I-STAT TOTAL HCG test for the rapid and accurate detection of HCG hormone in pregnant women
- The report provides granular level information about the market size, regional market share, and forecast from 2017-2023
- The report covers in-detail insights about the competitor’s overview, key findings, and their key strategies
- The report outlines drivers, restraints, challenges, and trends that are currently faced by the industry
- The report tracks recent innovations, key developments, and startup’s details that are working in the industry
- The report provides plethora of information about market entry strategies, regulatory framework, and reimbursement scenario